Endurance RP (RPGLF) AI Stock Analysis

Endurance RP

(Other OTC:RPGLF)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

High 2025 gross marginThe very high 2025 gross margin indicates that the company can retain substantial value from reported sales before operating costs. If maintained and paired with better expense control, this could provide operating leverage and support a path toward improved profitability, although the historical inconsistency limits confidence.

Negative Factors

Deepening lossesDeteriorating net margins and materially negative EBIT and EBITDA show that the business is not converting revenue into operating or bottom-line profit. Persistent losses can consume capital, restrict reinvestment capacity, and make any recovery dependent on substantial operational improvement.

Endurance RP (RPGLF) vs. SPDR S&P 500 ETF (SPY)

Market Cap: $1.72M
Dividend Yield: ―
Average Volume (3M): ―
Price to Earnings (P/E): -16.6
Beta (1Y): -2.28
Revenue Growth: 487.27%
EPS Growth: 62.36%
Country: US
Employees: 17
Sector: Healthcare
Sector Strength: 51
Industry: Medical - Pharmaceuticals

Endurance RP Business Overview & Revenue Model

Company Description

Regent Pacific Group Limited is an investment holding company that primarily focuses on the healthcare and life sciences sectors. The company is involved in the research, development, and sale of pharmaceutical products, with a notable focus on treat...

Endurance RP Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

RPGLF against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
HK:1217	75Outperform	HKD 128.02M	-4.54	-4.90%	―	-126.01%	-237.50%
HK:0310	52Neutral	HKD 84.47M	-6.60	-82.36%	―	―	79.32%
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
HK:0129	46Neutral	HKD 225.88M	-0.12	-16.70%	―	163.09%	52.42%
HK:1835	42Neutral	HKD 613.36M	-16.61	-13.47%	―	40.35%	-327.36%
HK:0339	39Underperform	HKD 291.60M	-39.94	-66.95%	―	―	-700.00%

* Healthcare Sector Average

Performance Comparison

RPGLF and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
RPGLF	Endurance Rp Limited	0.13	0.02	25.00%
HK:0129	Asia Standard International Group	0.16	-0.14	-47.00%
HK:1217	China Innovation Investment Limited	0.01	-0.00	-28.57%
HK:1835	Shanghai Realway Capital Assets Management Co., Ltd. Class H	4.00	1.80	81.82%
HK:0310	Prosperity Investment Holdings Limited	0.14	-0.10	-41.88%
HK:0339	Core Economy Investment Group Limited	0.68	0.52	327.22%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Endurance RP AI Stock Analysis